Academic Journal
Galunisertib combined with sorafenib affects in vivo tumor growth and immune landscape in hepatocellular carcinoma (HCC)
| العنوان: | Galunisertib combined with sorafenib affects in vivo tumor growth and immune landscape in hepatocellular carcinoma (HCC) |
|---|---|
| المؤلفون: | Tijeras-Raballand, A., Le Bitoux, M.A., Maillard, A., Albuquerque, M., Colnot, N., Barral, M., Dohan, A., Bonnin, P., Pocard, M., Benhadji, K., Paradis, V., Raymond, E., Harari, A., Faivre, S., De Gramont, A. |
| المصدر: | European Journal of Cancer ; volume 69, page S133 ; ISSN 0959-8049 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2016 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s0959-8049(16)32996-3 |
| الاتاحة: | http://dx.doi.org/10.1016/s0959-8049(16)32996-3 https://api.elsevier.com/content/article/PII:S0959804916329963?httpAccept=text/plain https://api.elsevier.com/content/article/PII:S0959804916329963?httpAccept=text/xml |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
| رقم الانضمام: | edsbas.1A77DBBE |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s0959-8049(16)32996-3 |
|---|